Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2001;104:2388-2390

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fischell, T. A.
Right arrow Articles by Virmani, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fischell, T. A.
Right arrow Articles by Virmani, R.

(Circulation. 2001;104:2388.)
© 2001 American Heart Association, Inc.


Editorials

Intracoronary Brachytherapy in the Porcine Model

A Different Animal

Tim A. Fischell, MD; Renu Virmani, MD

From the Heart Institute at Borgess Medical Center, Kalamazoo, Mich (T.A.F.), and the Department of Cardiovascular Pathology, Armed Forces Institute of Pathology, Washington, DC (R.V.).

Correspondence to Renu Virmani, MD, Department of Cardiovascular Pathology, Armed Forces Institute of Pathology, 6825, 16th Street NW, Washington, DC 20306-6000. E-mail virmani@afip.osd.mil


Key Words: Editorials • catheters • balloon • brachytherapy

Since the introduction of percutaneous coronary balloon angioplasty, restenosis has remained the most challenging problem facing interventional cardiologists. Stenting has reduced the need for clinically driven repeat revascularization, but has far from eliminated it. As early as 1989, intravascular brachytherapy was proposed as a means to ameliorate the proliferative component of restenosis after angioplasty. After promising results in early animal studies, brachytherapy was introduced as a treatment for the prevention of restenosis in clinical trials.1,2 This treatment was directed primarily at the very challenging subgroup of patients with in-stent restenosis.

See p 2459

In the present issue of Circulation Coussement et al3 describe an unfavorable 6-month outcome after catheter-based ß-irradiation in a porcine coronary model. The results described may provide some insights into the biology of restenosis inhibition with brachytherapy, or they may be a finding limited by the idiosyncrasies of this particular animal model and not directly relevant to humans. In this study, normal pig coronary arteries exposed to 20 or 30 Gy of ß-irradiation delivered by a 186Re-liquid filled balloon after overdistension balloon injury demonstrated greater neointimal areas and thrombosis at 6 months compared with nonirradiated vessels. On the basis of the discrepancy between the 6-month outcomes in clinical trials and these animal data, the investigators have proposed that the "direct extrapolation of the long-term outcome of endovascular irradiation in the pig coronary artery preparation of restenosis to the human setting is not appropriate."

Before we cast aside the utility of the various animal models of restenosis, we . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
C. Deiner, E. Shagdarsuren, P. L. Schwimmbeck, P. Rosenthal, C. Loddenkemper, U. Rauch, M. Pauschinger, R. Dietz, H.-P. Schultheiss, R. Dechend, et al.
Nf-{kappa}b and AP-1 activation is associated with late lumen loss after porcine coronary angioplasty and antiproliferative beta-irradiation
Cardiovasc Res, July 1, 2007; 75(1): 195 - 204.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
W. J.L. Suyker, J. P. Matonick, P. T.W. Suyker, A. Brutel de la Riviere, M. P. Buijsrogge, R. P.J. Budde, C. W.J. Verlaan, G. Pasterkamp, P. F. Grundeman, and C. Borst
S2 Connector Versus Suture: Distal Coronary Anastomosis Remodeling, Patency, and Function in the Pig
Circulation, July 4, 2006; 114(1_suppl): I-390 - I-395.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. S. Schwartz, N. A. Chronos, and R. Virmani
Preclinical restenosis models and drug-eluting stents: Still important, still much to learn
J. Am. Coll. Cardiol., October 6, 2004; 44(7): 1373 - 1385.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. Lafont
The Cypher stent: no longer efficacious at three months in the porcine model?
Cardiovasc Res, September 1, 2004; 63(4): 575 - 576.
[Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
W. J. L. Suyker, M. P. Buijsrogge, P. T. W. Suyker, C. W. J. Verlaan, C. Borst, and P. F. Grundeman
Stapled coronary anastomosis with minimal intraluminal artifact: The S2 Anastomotic System in the off-pump porcine model
J. Thorac. Cardiovasc. Surg., February 1, 2004; 127(2): 498 - 503.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
C. J. van Andel, P. V. Pistecky, P. F. Grundeman, M. P. Buijsrogge, and C. Borst
Permanent wall stretching in porcine coronary and internal mammary arteries
Ann. Thorac. Surg., September 1, 2003; 76(3): 805 - 809.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
C. J. van Andel, P. V. Pistecky, and C. Borst
Mechanical properties of porcine and human arteries: implications for coronary anastomotic connectors
Ann. Thorac. Surg., July 1, 2003; 76(1): 58 - 64.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. P. Buijsrogge, C. W. J. Verlaan, P. F. Grundeman, and C. Borst
Briefly occlusive coronary anastomosis with tissue adhesive
J. Thorac. Cardiovasc. Surg., February 1, 2003; 125(2): 385 - 390.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. P. Buijsrogge, C. W.J. Verlaan, M. H.P. van Rijen, P. F. Grundeman, and C. Borst
Coronary end-to-side sleeve anastomosis using adhesive in off-pump bypass grafting in the pig
Ann. Thorac. Surg., May 1, 2002; 73(5): 1451 - 1456.
[Abstract] [Full Text] [PDF]